Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 8/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8027045 | 0.99 | F2 (0.45) | F2CNR2SMN1; SMN2ACSL1PAX8 | |
| SCHEMBL6635980 | 0.89 | SMN1; SMN2 (0.42) | F2SMN1; SMN2PAX8POLBLMNA | |
| SCHEMBL6635646 | 0.87 | PPARG (0.43) | F2CNR2SMN1; SMN2PAX8POLB | |
| SCHEMBL8026562 | 0.84 | F2 (0.67) | F2 | |
| SCHEMBL8027395 | 0.83 | F2 (0.52) | F2SMN1; SMN2PAX8POLBLMNA | |
| Hydrochloric Acid SCHEMBL8028460 | 0.83 | F2 (0.66) | F2 | |
| SCHEMBL8026422 | 0.83 | F2 (0.55) | F2SMN1; SMN2ACSL1PAX8POLB | |
| Hydrochloric Acid SCHEMBL8027015 | 0.82 | F2 (0.65) | F2 | |
| SCHEMBL8032933 | 0.81 | F2 (0.53) | F2SMN1; SMN2ACSL1PAX8POLB | |
| SCHEMBL8027058 | 0.79 | F2 (0.70) | F2SMN1; SMN2PAX8POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1060166-A1 | FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS | Boehringer Ingelheim Pharma KG (DE) | 2000-12-20 | — | — | EP | disclosed |
| US-6114532-A | ANTICOAGULANT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-05 | — | — | US | disclosed |
| WO-1999040072-A1 | FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-08-12 | — | — | WO | disclosed |